National Research Council of Canada-Pharmaceuticals & Healthcare-Deals and Alliances Profile
August 2017
26
About the Report
About the Report
Summary
National Research Council of Canada (NRC) is a research and technology institution that offers scientific and technical services. It offers wide range of services such as testing and certifications, calibration, prototyping, demonstrations, scale-up and consulting among others. The organization through its Industrial Research Assistance Program offers networking opportunities and linkages; knowledge transfer; business and management skills development; and financial support to small and medium-sized enterprises. It caters its services to agriculture, aquaculture, construction, defense and security, energy, oil and gas, health sciences, Information and communications technology, aerospace, automotive, marine and others industries. NRC is headquartered in Ottawa, Ontario, Canada.
National Research Council of Canada-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.
Scope
Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.
Business Description-A brief description of the company's operations.
Key Employees-A list of the key executives of the company.
Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.
Key Competitors-A list of the key competitors of the company.
Key Recent Developments-A brief on recent news about the company.
Reasons to Buy
Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company's business segments' expansion / divestiture strategy
The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.
Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.
Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.
The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note: Some sections may be missing if data is unavailable for the company.
Products
Products
National Research Council of Canada, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.
Table of Contents
Table of Contents
Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
National Research Council of Canada, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
National Research Council of Canada, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
National Research Council of Canada, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
National Research Council of Canada, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
National Research Council of Canada, Medical Devices Deals, 2011 to YTD 2017 9
National Research Council of Canada, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
National Research Council of Canada, Pharmaceuticals & Healthcare, Deal Details 11
Venture Financing 11
Appili Therapeutics Raises USD2.5 Million in Seed Financing Round 11
Partnerships 12
Advanced Proteome Therapeutics Enters into Agreement with National Research Council of Canada 12
Kalgene Pharma Enters into Agreement with National Research Council of Canada 13
National Research Council Enters into Co-Development Agreement with Zymeworks for Cancer 14
AvidBiologics Enters Into Co-Development Agreement With National Research Council of Canada 15
Tianjin CanSino Biotech Enters into Agreement with National Research Council of Canada 16
CDRD Enters Into Preferred Collaboration With National Research Council 17
National Cheng Kung University Enters Into An Agreement With National Research Council of Canada 18
Licensing Agreements 19
Helix BioPharma Enters into Licensing Agreement with National Research Council of Canada 19
Kalgene Pharma Enters into Licensing Agreement with National Research Council of Canada 20
National Research Council of Canada-Key Employees 21
National Research Council of Canada-Locations And Subsidiaries 22
Head Office 22
Other Locations & Subsidiaries 22
Recent Developments 23
Government and Public Interest 23
Mar 20, 2017: Canadian collaboration to accelerate development of cancer treatments 23
Oct 03, 2016: KalGene gears up to manufacture and test promising Alzheimer's treatment with NRC, McGill and CIMTEC 25
Appendix 26
Methodology 26
About GlobalData 26
Contact Us 26
Disclaimer 26
List of Figure
List of Figures
National Research Council of Canada, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 2
National Research Council of Canada, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 2
National Research Council of Canada, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 2
National Research Council of Canada, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 2
National Research Council of Canada, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
National Research Council of Canada, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 6
National Research Council of Canada, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
National Research Council of Canada, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
National Research Council of Canada, Medical Devices Deals, 2011 to YTD 2017 9
List of Table
List of Tables
National Research Council of Canada, Pharmaceuticals & Healthcare, Key Facts 2
National Research Council of Canada, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
National Research Council of Canada, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
National Research Council of Canada, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
National Research Council of Canada, Deals By Therapy Area, 2011 to YTD 2017 8
National Research Council of Canada, Medical Devices Deals, 2011 to YTD 2017 9
National Research Council of Canada, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Appili Therapeutics Raises USD2.5 Million in Seed Financing Round 11
Advanced Proteome Therapeutics Enters into Agreement with National Research Council of Canada 12
Kalgene Pharma Enters into Agreement with National Research Council of Canada 13
National Research Council Enters into Co-Development Agreement with Zymeworks for Cancer 14
AvidBiologics Enters Into Co-Development Agreement With National Research Council of Canada 15
Tianjin CanSino Biotech Enters into Agreement with National Research Council of Canada 16
CDRD Enters Into Preferred Collaboration With National Research Council 17
National Cheng Kung University Enters Into An Agreement With National Research Council of Canada 18
Helix BioPharma Enters into Licensing Agreement with National Research Council of Canada 19
Kalgene Pharma Enters into Licensing Agreement with National Research Council of Canada 20
National Research Council of Canada, Key Employees 21
National Research Council of Canada, Other Locations 22
Why Buy From US?
What makes us stand out is that our consultants follows Robust, Refine and Result (RRR) methodology. i.e. Robust for clear definitions, approaches and sanity checking, Refine for differentiating respondents facts and opinions and Result for presenting data with story
We have set a benchmark in the industry by offering our clients with syndicated and customized market research reports featuring coverage of entire market as well as meticulous research and analyst insights.
While we don't replace traditional research, we flip the method upside down. Our dual approach of Top Bottom & Bottom Top ensures quality deliverable by not just verifying company fundamentals but also looking at the sector and macroeconomic factors.
With one step in the future, our research team constantly tries to show you the bigger picture. We help with some of the tough questions you may encounter along the way: How is the industry positioned? Best marketing channel? KPI's of competitors? By aligning every element, we help maximize success.
Our report gives you instant access to the answers and sources that other companies might choose to hide. We elaborate each steps of research methodology we have used and showcase you the sample size to earn your trust.
If you need any support, we are here! We pride ourselves on universe strength, data quality, and quick, friendly, and professional service.